Literature DB >> 17824904

Bone mass in elderly patients with Parkinson's disease.

B Lorefält1, G Toss, A-K Granérus.   

Abstract

OBJECTIVE: The objective of the present study was to find risk factors for low bone mineral density (BMD) in patients with Parkinson's disease (PD).
MATERIAL AND METHODS: Twenty-six PD patients and 26 age-and sex-matched healthy controls were assessed twice within a 1-year period. PD symptoms, body weight, body fat mass, BMD, physical activity, smoking and serum concentrations of several laboratory analyses were investigated.
RESULTS: BMD in different locations was lower in PD patients compared with their controls and decreased during the investigated year. BMD was lower in PD patients with low body weight. BMD Z-score of trochanter in the PD group was directly correlated to the degree of physical activity and indirectly to the length of recumbent rest. Total body BMD Z-score in the PD group was directly correlated to the degree of rigidity. Serum 25-hydroxy-vitamin D was slightly lower in PD patients.
CONCLUSION: Low body weight and low physical activity were risk factors for low BMD in PD, while rigidity seemed to be protective.

Entities:  

Mesh:

Year:  2007        PMID: 17824904     DOI: 10.1111/j.1600-0404.2007.00875.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  11 in total

Review 1.  How might physical activity benefit patients with Parkinson disease?

Authors:  Arlène D Speelman; Bart P van de Warrenburg; Marlies van Nimwegen; Giselle M Petzinger; Marten Munneke; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

2.  Progression of postural changes in Parkinson's disease: quantitative assessment.

Authors:  Alexander Khlebtovsky; Ruth Djaldetti; Yaniv Rodity; Ofir Keret; Gloria Tsvetov; Ilana Slutzcki-Shraga; Felix Benninger
Journal:  J Neurol       Date:  2017-02-02       Impact factor: 4.849

Review 3.  Musculoskeletal problems in Parkinson's disease.

Authors:  Young Eun Kim; Beom S Jeon
Journal:  J Neural Transm (Vienna)       Date:  2013-02-19       Impact factor: 3.575

4.  Relative mortality in U.S. Medicare beneficiaries with Parkinson disease and hip and pelvic fractures.

Authors:  Marcie Harris-Hayes; Allison W Willis; Sandra E Klein; Sylvia Czuppon; Beth Crowner; Brad A Racette
Journal:  J Bone Joint Surg Am       Date:  2014-02-19       Impact factor: 5.284

Review 5.  Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

Authors:  S Binks; R Dobson
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

6.  Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study.

Authors:  M E L Arbouw; K L L Movig; T P van Staa; A C G Egberts; P C Souverein; F de Vries
Journal:  Osteoporos Int       Date:  2010-10-22       Impact factor: 4.507

7.  Role of vitamin d in Parkinson's disease.

Authors:  Khanh L Ng; Lan Nguyễn
Journal:  ISRN Neurol       Date:  2012-03-07

8.  Lower Energy Intake among Advanced vs. Early Parkinson's Disease Patients and Healthy Controls in a Clinical Lunch Setting: A Cross-Sectional Study.

Authors:  Petter Fagerberg; Lisa Klingelhoefer; Matteo Bottai; Billy Langlet; Konstantinos Kyritsis; Eva Rotter; Heinz Reichmann; Björn Falkenburger; Anastasios Delopoulos; Ioannis Ioakimidis
Journal:  Nutrients       Date:  2020-07-16       Impact factor: 5.717

Review 9.  Bone health in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Kelli M Torsney; Alastair J Noyce; Karen M Doherty; Jonathan P Bestwick; Ruth Dobson; Andrew J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-03-11       Impact factor: 10.154

10.  Bone Mineral Density and Body Composition in Males with Motor Neuron Disease: A Study from Teaching Hospital in Southern Part of India.

Authors:  Basavaraj G Sooragonda; Sandeep Agarwal; Rohit Ninan Benjamin; A T Prabhakar; Ajith Sivadasan; Nitin Kapoor; Kripa E Cherian; Felix K Jebasingh; Sanjith Aaron; Nihal Thomas; Vivek Mathew; Hesarghatta S Asha; Thomas V Paul
Journal:  Ann Indian Acad Neurol       Date:  2020-08-28       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.